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The functional properties of T  and B  lymphocytes and the nature of their 
participation in the immune response have been elucidated to a large extent in 
recent years (1). Evidence of  functional heterogeneity within the T-cell compart- 
ment has been garnered by utilizing surface markers which distinguish subsets 
of cells (2). Although B cells also carry distinctive surface markers, evidence of 
functional subpopulations in the B-cell compartment is scant. B-cell heterogene- 
ity was initially suggested by Playfair and Purves (3), who reported a differen- 
tial capacity of B cells from diverse anatomical regions to synergize with T cells. 
Additional support can be found in fractionation studies in which cells capable of 
responding to T-dependent and T-independent forms of hapten-carrier conju- 
gates were separable by velocity sedimentation (4). 
Our laboratory has been engaged in studies of the immune response to the 
azobenzenearsonate  epitope  in  mono-,  bi-,  and  polyfunctional forms  (5,  6). 
Previous efforts have utilized the guinea pig as the laboratory model, since 
guinea pigs  make vigorous cellular  immune responses to  small  mono- and 
bifunctional azobenzene-p-arsonate (ABA)  1 derivatives. The present communi- 
cation describes the initial phases of an investigation of the murine response to 
polyfunctional ABA  conjugates.  The  findings indicate that  strain  A/J  mice 
make plaque-forming cell (PFC) responses to the ABA epitope only when it is 
presented in  a  T-dependent form,  and  that the  C3  receptor is  a  functional 
marker for murine B cells which respond to many T-dependent antigens (hap- 
ten-protein conjugates). Further, C3 may be an obligatory component in the 
pathway that leads to these T-dependent antibody responses, but the C3 recep- 
tor is apparently unexpressed on the surfaces of B cells which make T-independ- 
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ent antibody responses. These findings are in general accord with recent reports 
from other laboratories (7, 8). 
Materials and Methods 
Antigens and Immunization.  Giant keyhole limpet hemocyanin (KLH) and bovine IgG (BGG) 
were obtained from Calbiochem, Los Angeles, Calif., and Miles Laboratories, Inc., Miles Research 
Div., Kankakee,  Ill., respectively. Ficoll was obtained from Pharmacia Fine Chemicals, Inc., 
Piscataway, N. J. Escherichia coli lipopolysaccharide (LPS) K235 was supplied by Abbot Laborato- 
ries, Chicago, Ill. Concanavalin A (Con A) was purchased from Miles Laboratories, Inc., Miles 
Research Div. All other reagents were purchased from Eastman Organic Chemicals Div., East- 
man Kodak Co., Rochester, N. Y. 
Conjugation of ABA was performed according to the method of Tabachnick and Sobotka (9), 
while 2,4-dinitrephenyl (DNP)-protein conjugates were prepared as described by Eisen (10). 2,4- 
Dinitrophenyl-aminoethyl-carbamyl  methyl  (DNP87)-Ficoll  and  aminoethyl-carbamyl  methyl 
(AECM~5o)-Ficoll  were prepared according to the method used by Inman (11). A mono-substituted 
conjugate ofp-hydroxyphenyl-prepionic acid (DRAT) was synthesized as described in an earlier 
publication (5). DRAT was coupled to AECM~5o-Ficoll  by generating the N-hydroxysuccinimide 
ester of DRAT with dicyclohexylcarbodiimide, and reacting the active ester with AECM~.-Ficoll 
in aqueous dimethylformamide. The resulting m-azobenzene-p'-arsonate-3-p-hydroxyphenyl-pro- 
pionyl-aminoethyl-carbamyl methyl-Ficoll (ABA-Ficoll) was purified by dialysis and chromatog- 
raphy. 
Female A/J and C57BL/6 mice 6-8 wk of age were purchased from The Jackson Laboratory, Bar 
Harbor, Maine and from Simonsen Laboratories, Gilroy, Calif., respectively. 
For primary  immunization,  50  ~g ABA-KLH or 250  ~g DNP-BGG emulsified in  complete 
Freund's  adjuvant  (Difco  Laboratories,  Madison,  Wis.),  was  administered  intraperitoneally. 
Secondary immunization with ABA-KLH consisted of a single intraperitoneal injection of 50 ~g of 
ABA-KLH dissolved in saline. All other antigens were administered intravenously in saline. 
Plaque Assay.  The technique of Cunningham and Szenberg (12) as described by Jerne et al. 
(13) was employed to detect the presence of antibody-forming cells. ABA-medified sheep erythro- 
cytes (SRBC) were prepared at 0°C by reacting 0.12 ml of 0.111 M diazotized arsanilic acid with 10 
ml of a  thrice washed  5%  SRBC  suspension  in phosphate-buffered  saline  (PBS),  pH  7.4. The 
reaction was terminated after 10 min by washing with cold PBS. 2,4,6-trinitrophenyl-modiflod 
indicator cells were prepared by adding 2 ml of a  0.5%  (wt/vol) solution of 2,4,6-trinitrobenzene 
sulfonic acid to 3 ml of PBS containing 0.5 ml of thrice washed SRBC. The reaction was allowed to 
proceed for 10 rain at bench temperature followed by extensive washings with PBS and finally 
with plaquing medium. 
Rosette Assay.  The hapten-specific rosette assay is described in detail elsewhere (14). Briefly, 
single spleen cell suspensions were prepared with PBS containing sodium azide (1,000 ~ag/ml) at a 
final concentration of 4  ×  107 viable cells/ml. One volume of spleen cells was mixed with one 
volume of PBS or PBS containing 5  ×  10  -~ M L-tyrosine ABA (RAT) and allowed to stand  at 
ambient temperature for 30 rain in order to facilitate receptor equilibration. An equal volume of 
2% ABA-SRBC was added, the preparation chilled to 0°C, and centrifuged at 50g for 10 rain in a 
refrigerated  centrifuge.  The  pelleted preparations  were  allowed to  stand  for 30  min  at  0°C, 
followed  by  resuspension  in  the  cold on  a  rotator  for  10  rain  at  10  rpm/min.  Rosettes were 
enumerated in counting chambers constructed from glass slides and cover slips using double stick 
tape. A minimum of 100 rosettes were scanned for each point. 
C3 Depletion.  Transient C3 depletion was achieved according to the method of Pepys (7). Each 
mouse received four intraperitoneal injections of cobra venom factor (CoV) (Cordis  Laboratories, 
Miami, Fla.) at 8-h intervals. The dose ratio for CoV treatment was 200 U/kg body weight (i.e., 
approximately 4 units/mouse). Animals were immunized immediately after the last injection of 
CoV and assays for  direct  and indirect  PFC were performed 7 days later. 
Detection  and Depletion  of  Complement Receptor  Lymphocytes (CRL).  Unpeolod SRBC  (Colo- 
rado Serum Co., Denver, Colo.)  were washed three times and sensitized  with a subagglutinating 
concentration of 19S rabbit anti-SRBC in veronal buffer,  pH 7.2,  containing 0.1% gelatin,  Ca  ++ 
Mg  ++ (GVB). Sensitization  was allowed to proceed at 37°C for 30 min and was terminated by 
washing three times with GVB  containing 0.01 M  EDTA, followed by two additional  washes in 384  SUBPOPULATION  OF  B  CELLS 
GVB.  The sensitized SRBC were reacted for 30 min at 37°C  with a  1:4 dilution of CS-deficient 
mouse serum. The resulting SRBC sensitized with rabbit anti-SRBC antibody and then sensitized 
with mouse C3 (EAC) were washed once with GVB-EDTA and twice with GVB. 
Spleen cell suspensions were prepared as described above, freed of erythrocytes by lysis with 
NI-LC1,  and washed into RPMI-1640 medium containing 10% heat-inactivated fetal calf serum. 
EAC rosettes were formed by mixing 5  x  107 spleen cells with 1 ×  10  ~ EAC in 4 ml total volume. 
The  mixture  was  rotated  at  bench  temperature  for  30  min  followed  by  centrifugation.  The 
supernate  was  removed  and the  cells  resuspended  in 2  ml  of fresh medium  by rotation.  The 
fraction of rosetting cells was determined immediately in chambers described for the hapten- 
specific rosette assay. A minimum of 100 rosettes were scored for each assay. 
Populations of spleen cells enriched for B  cells were prepared by treatment with anti-Thy-1 
serum (15) or by eluting the adherent cell population from a nylon wool column (16). The anti-Thy- 
1 serum was cytotoxic for about 40% of mouse spleen cells and 100% of thymic lymphocytes. EAC 
were formed and the rosetted [CRL(+)] and nonrosetted [CRL(-)] cells were separated  (17)  and 
treated with isotonic NH4C1 to lyse RBC and washed in preparation for the Mishell-Dutton assay. 
Cell Cultures.  Fractionated splenic B cells were cultured (18) in medium containing 5  ×  10 -5 
M 2-mercaptoethanol. 
Mitogen-Induced Proliferation.  Mitogens were dissolved or suspended in RPMI-1640 and 0.1 
ml was added to each culture. Control cultures received 0.1 ml RMPI-1640.  Preliminary studies 
established 0.5 ~g as the optimal concentrations for LPS and Con A, respectively. Five hundred 
thousand lymphocytes suspended in 0.5 ml of RPMI-1640 containing 5% fetal calf serum (Grand 
Island Biological Co., Berkeley, Calif.) were cultured with or without mitogen for 3 days. On the 
last day of culture, 0.2 ~Ci of [methyl-l~C]thymidine in 0.5 ml of RPMI-1640 was added. Prolifera- 
tion was terminated by washing the cultures onto glass fiber filters followed succesively by TCA 
and methanol washes. After drying, incorporated radioactivity was determined by liquid scintilla- 
tion spectrometry. 
Results 
PFC Response of  A/J Mice to ABA on a Thymic-Dependent Carrier.  Murine 
anti-ABA PFC have been difficult to demonstrate  (19),  probably owing to the 
relatively rigid antigen dosage and immunization schedule found to be essential 
in this laboratory. In our experiments, primary responses were never seen, but 
priming with 50 ~g of ABA-KLH in complete Freund's adjuvant (CFA) followed 
5 wk later by a booster injection of 50 ~g of the conjugate in saline consistently 
yielded significant indirect PFC responses on the 4th day after boosting (111,000 
_+ 8,000/spleen; Fig. 1). Priming with carrier alone was insufficient to induce an 
anti-ABA PFC response to a secondary injection of ABA-KLH (Fig. 1). No direct 
plaques  were recorded after either the priming or boosting injections of ABA- 
KLH.  The secondary PFC response is of very limited duration,  as background 
levels were observed again by day 9 (Fig. 1). Although priming with ABA-KLH 
did not induce a PFC response, an increase in spleen cells which formed rosettes 
with ABA-SRBC occurred. After priming,  the rosette-forming cell (RFC) level 
rose from a  background  of 1.1/104  spleen cells to 5/10  ~ cells.  The formation of 
rosettes was inhibitable by RAT. 
PFC Response of A/J Mice to ABA on a Thymic-Independent Carrier.  Since 
hapten-Ficoll conjugates have been reported to generate T-independent IgG as 
well as IgM antibody production (20), Ficoll was selected as a promising carrier 
to test the ability of A/J mice to respond to the ABA determinant in a thymic- 
independent form. Accordingly,  ABA was linked to AECM-Ficoll via an active 
ester of DRAT and the resulting conjugate, ABA-Ficoll, as well as DNP-Ficoll, 
were employed as immunogens. AECM-Ficoll proved to be a suitable carrier for 
the DNP haptenic determinant, as anti-DNP direct PFC responses in the range 385 
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FIG.  1.  Secondary indirect PFC response to ABA-KLH in A/J mice primed with either 50 
~g KLH (squares) or 50 ~g ABA-KLH (circles) in CFA and boosted with 50 ~g ABA-KLH in 
saline 5 wk postpriming. 
of 4-8  x  104 per spleen were obtained with an antigen dose range of 1-100 ftg 
(Fig. 2). Although only direct PFC responses are shown, about 104 indirect anti- 
DNP  PFC  per spleen were observed by day 7.  In contrast,  ABA-Ficoll was 
unable to induce a perceptible anti-ABA PFC response over a similar time and 
dose range. As few as 103 PFC per spleen could readily have been detected by the 
assay.  Although only responses on  days 4  and  5  are  illustrated  in  Fig.  2, 
negative results for anti-ABA direct and indirect PFC were obtained up to 28 
days postimmunization. In addition to the absence of a PFC response to ABA- 
Ficoll, the level of detectable anti-ABA RFC declined after immunization from a 
background of 1.1/104 to 0.5/105 spleen cells. 
Inability of ABA-KLH to Expand an ABA Precursor Population Responsive 
to ABA-Ficoll.  The absence of a detectable primary response to ABA-KLH and 
the requirement for priming with ABA-KLH, as opposed to KLH alone, sug- 
gests that the frequency  of ABA-specific B-cell precursors in the A/J mouse may 
be low. IfB cells responsive to ABA-KLH can be triggered by ABA coupled to T- 
independent carriers, then it might be expected that priming with ABA-KLH 
and boosting with ABA-Ficoll would produce a significant anti-ABA response, 
as occurs when boosting with the homologous immunogen. Groups of three A/J 
mice were primed with 50/~g of ABA-KLH and boosted 5 wk later with 10, 100, 
or 1,000/~g of ABA-Ficoll or with 50/~g of ABA-KLH. The animals primed and 386 
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boosted with ABA-KLH had a mean of 31,107 _+ 2,202 indirect PFC per spleen, 
whereas all groups of mice boosted with ABA-Ficoll were negative (Table I). 
These results suggest that ABA-Ficoll is incapable of triggering memory B cells 
generated by ABA-KLH. 
Ability of ABA-Ficoll to Abrogate  the anti-ABA Response to ABA-KLH.  In 
order to exclude the inability of ABA-Ficoll to reach immunocompetent cells as 
an explanation for its apparent nonimmunogenicity, experiments designed to 
assess its tolerogenicity  were carried out. Virgin A/J mice or animals which had 
been primed with ABA-KLH were given three injections of 200 ~g ABA-Ficoll at 
24-h intervals; immediately after the last injection, the mice were either primed 
or boosted with 50 ~g ABA-KLH. Indirect PFC were determined 5 days after 
boosting. Administration of ABA-Ficoll before either priming or boosting with 
ABA-KLH reduced the secondary indirect PFC response by approximately 90% 
(Table II). In contrast, the anti-DNP PFC response to DNP-KLH was unaffected 
by identical treatment with ABA-Ficoll. These results indicate that ABA-Ficoll 
does reach immunocompetent spleen cells capable of responding to the ABA 
epitope. They are consistent with the observation that detectable RFC for ABA- 
SRBC  decline after injection of ABA-Ficoll, but the relationship of RFC  to 
precursors of PFC is unknown. 
Effect of C3 Depletion on Anti-Hapten T-Dependent  and T-Independent Re- 
sponses.  The foregoing results suggest the possibility that different subpopula- G.  K.  LEWIS,  R.  RANKEN,  D.  E.  NITECKI,  AND  J.  W.  GOODMAN 
TABLE  I 
Inability of ABA-KLH to Expand an ABA-Specific B-Cell Precursor 
Population Responsive to ABA-Ficoll 
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Group*  Priming injection  Boosting injections  PFC/spleen§ 
I  50 ~g ABA-KLH  50 ftg ABA-KLH  31,107  _+  2,202 
II  50 ~g ABA-KLH  10 ~g ABA-Ficoll  <1,000 
III  50 ~g ABA-KLH  100 ~g ABA-Ficoll  <1,000 
IV  50 ~g ABA-KLH  1000 ~g ABA-Ficoll  <1,000 
* Three A/J mice per group. 
* 5 wk ai~r priming injection. 
§ Assayed 4 days after boosting injection. 
TABLE II 
Ability of ABA-FicoU to Abrogate the Anti-ABA Response to ABA-KLH in A/J Mice 
Group*  ABA-Ficoll*  ABA-KLH ~  5 wk --* ABA-Ficoll  ABA-KLH  PFC/spleen 
I  -  50 ~g  -  50 ~g  45,238  -+ 3,485 
II  3  ×  200 ~g  50 ~g  -  50 ~g  5,249  -+ 2,601 
III  -  50 ~g  3  ×  200 ~g  50 ~g  4,666  _+  577 
* Four mice per group. 
Administered at 24-h intervals in saline intraperitoneally. 
tions of B lymphocytes may be involved in antibody responses to T-dependent 
and T-independent antigens. According to this scenario, anti-DNP precursors 
would reside in both B-cell compartments of A/J mice, based on anti-DNP PFC 
responses  to  DNP  conjugates  of T-dependent  and  T-independent  carriers, 
whereas anti-ABA precursors would reside largely or exclusively in  the  T- 
dependent compartment.  In  order  to  critically evaluate  this  hypothesis,  a 
marker other than antigen responsiveness capable of discriminating between B 
cells was required. Pepys has reported a differential effect of C3 depletion by 
CoV on murine responses to T-dependent and T-independent antigens (7). The 
antigens which he used were SRBC and polyvinylpyrolidone,  and it is difficult to 
assess to what degree epitope differences between the two might have been 
responsible for the effect observed. In addition, only IgM responses to the T- 
independent antigen were reported,  leaving the possibility that  C3  may be 
essential for IgG responses to T-independent as well as to T-dependent antigens. 
In  order to  circumvent these  ambiguities,  responses to  the  same  epitope 
(DNP) on a T-dependent carrier (BGG) and on a T-independent carrier (Ficoll) 
were assayed in C57BL/6 mice, which were used because they make vigorous T- 
independent IgG as well as IgM responses to DNP-Ficoll (20). However, paren- 
thetically, we subsequently found that A/J mice make comparable IgG PFC 
responses to DNP-Ficoll. Both the IgM and IgG PFC responses to DNP-BGG 
were suppressed by approximately 90% in mice depleted of C3 as described by 
Pepys, whereas the IgM and IgG responses to DNP-Ficoll were unaffected by 
prior C3  depletion (Table III).  These clear-cut results are similar to those of 
Pepys (7) and suggest the involvement of C3, or a product of activated C3, in T- 
dependent antibody responses but not in T-independent responses. They further 
show that T-independent IgG as well as IgM responses are refractory to C3 
depletion. 388  SUBPOPULATION  OF  B  CELLS 
TABLE  III 
The Effect of C3 Depletion by CoV on PFC Responses to DNP-BGG and DNP-Ficoll 
in C57BL]6 Mice 
CoY 
treat-  Antigen  Direct PFC/spleen  Reduc-  Indirect  PFC/  Reduc- 
ment  tion  spleen  tion 
%  % 
-  DNP-BGG  78,776 ~- 16,512  109,736 _+ 19,608 
+  DNP-BGG  7,560 •  3,780  90  12,180 _+ 1,260  89 
-  DNP-Ficoll  87,837 _+ 15,678  79,998 _+ 9,648 
+  DNP-Ficoll  210,745  _* 23,872  0  169,715  +_ 27,602  0 
The  effect of C3  depletion  on hapten-specific  memory was investigated  by 
treating groups of A/J mice with CoV before priming, before boosting, or before 
both priming and boosting with ABA-KLH. C3 depletion before priming caused 
a  moderate  depression of the  anti-ABA PFC  response  (ca.  50%),  as did CoV 
treatment  before priming  and  boosting  (Fig.  3).  However, the  most  marked 
effect (75%  depression) was observed in mice treated  only before the booster 
injection of antigen.  Since depletion of C3 is transient,  lasting about 4 days (6, 
21),  it  is not  surprising  that  the  response was only moderately depressed in 
animals  depleted only before priming.  Sufficient  antigen  probably remained 
after C3 recovery to prime to some degree. The relative ineffectiveness of CoV 
administered  before  both  priming  and  boosting  may  be  attributable  to  its 
immunogenicity (6, 21), since neutralizing antibody would attenuate the effect 
of the dose given before the second injection of antigen. The observation that the 
anti-ABA  PFC  response  was  depressed  approximately  75%  when  CoV  was 
administered only before boosting indicates that the triggering of memory cells, 
as well as their induction,  is dependent on the presence of C3. 
In Vitro Response of Splenic CRL( +) and CRL(-) B Cells to a T-Independent 
Antigen.  The insensitivity of the in vivo anti-DNP-Ficoll response to C3 deple- 
tion by CoV could be due to an absence of C3 receptors on the responding cell 
population, or, alternatively, receptors might be present but not required for the 
response  to  T-independent  antigens.  In  order  to  distinguish  between  these 
alternatives,  spleen  cells from  C57BL/6 mice  were fractionated  first  into  an 
enriched B-cell population by recovery from nylon wool or treatment with anti- 
Thy-1 serum, and then the B-cell fraction was resolved into CRL(+) and CRL(-) 
cells by EAC rosette formation. The CRL(+) cells comprised about 30% of the 
total spleen cell population. The subfractions as well as unrosetted B cells were 
cultured in vitro for 4 days at a  density of 5  ×  10  ~ cells/ml.  Cultures received 
either  saline  or  10  ng  of DNP-Ficoll,  a  quantity  determined  by preliminary 
experiments to be the optimal immunogenic dose for splenic B cells. 
The CRL(-) fraction made the best PFC response to DNP-Ficoll, averaging 
238 _+ 42 PFC per culture (Fig. 4). The response of the mixed B-cell population 
was substantially lower (164 _+ 17 PFC per culture), the difference between the 
two groups being statistically significant (0.05 > p). The response of the CRL(+ ) 
fraction was the lowest of the three  (37  +_ 20 PFC per culture). The difference 
between  the  responses  of the  CRL(+)  and  CRL(-)  populations  was  highly 
significant  (0.001  >  p).  Only direct PFC were detected in these experiments, G.  K.  LEWIS,  R.  RANKEN,  D.  E.  NITECKI,  AND  J.  W.  GOODMAN 
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owing perhaps to the reduced cell  density used in the cultures,  which was 
necessitated  by the small yield  of  CRL(-) cells. 
The results  of  these experiments indicate  that the splenic  B-cell  population 
responsive to DNP-Ficoll, and presumably to T-independent antigens in gen- 
eral,  does not  bear a receptor  for  C3. They also  strengthen the suggestion from 
the in vivo C3-depletion experiments that distinct  subpopulations of B  cells 
respond to  T-dependent and T-independent antigens. 
In Vitro Response of Splenic CRL( +) and CRL(-) B  Cells to a T-Dependent 
Antigen.  The preceding experiments with  DNP-Ficoll  established that  the 
response to that antigen is essentially restricted to CRL(-) B cells, but did not 
exclude the possibility that CRL(-) cells might also cooperate with T cells in T- 
dependent antibody responses. In order to investigate this further, CRL(+) and 
CRL(-) B cells were assayed for PFC responses to a  T-dependent antigen in 
vitro. Since it had been reported that substantial levels of anti-SRBC antibody 390  SUBPOPULATION  OF  B  CELLS 
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Fza.  4.  Response of splenic B-cell populations from C57BL/6 mice to DNP-Ficoll.  B  cells 
were prepared from whole spleens using nylon wool and further fractionated on the basis of 
the C3 receptor. Direct PFC were assayed on day 4 after culture initiation. 
were detectable in CoV-treated mice, though less than in untreated animals 
(21), suggesting the possibility of CRL(-) B-cell responses to this antigen, SRBC 
was selected as the T-dependent antigen in the present study. 
Spleen cells from C57BL/6 mice primed 4 days previously with 4 × 108 SRBC 
per mouse were fractionated into CRL(+)  and CRL(-) populations by EAC 
rosetting. The CRL(+) population was assumed to consist exclusively of B cells, 
which was supported by the inability of 107 CRL(+) cells to respond to SRBC in 
vitro  (data not shown).  On  the  other hand,  the  CRL(-) fraction contained 
primed T cells and accessory cells in addition to CRL(-) B cells.  No rosettes 
were observed after scanning 3  x  103  cells after rerosetting of the  CRL(-) 
fraction; hence, contamination with CRL(+) cells was much less than 1%. 
Various percentages of CRL(+) and CRL(-) cells were cultured with 3 ×  106 
SRBC for 5 days, at which time the cultures were assayed for IgM PFC. Cultures 
of unfractionated spleen cells in the absence of SRBC provided a background of 
approximately 100  PFC  per  culture  (Fig.  5).  Titration  of CRL(+)  cells by 
addition to the CRL(-) fraction yielded a linear cell dose-PFC response between 
0 and 30% CRL(+) cells with a  slope of approximately 3,100 IgM PFC per 106 
CRL(+) cells (Fig.  5). The response plateaued between 30 and 50%, suggesting G.  K.  LEWIS,  R.  RANKEN,  D.  E.  NITECKI,  AND  J.  W.  GOODMAN 
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FIG. 5.  Response of splenic B-cell  populations from C57BL/6 mice to SRBC. CRL(+) B 
cells  were prepared by  formation of  EAC rosettes.  Cultures contained 107  cells  comprised of 
varying  proportions of  CRL(+) and CRL(-) fractions.  The T-cell  dependence of  the  CRL(-) 
PFC response was assessed by treatment with anti-Thy-I serum and complement before 
culturing. Direct PFC were assayed on day 5 after  culture initiation. 
that CRL(+) cells  were no longer limiting.  The normal frequency of CRL(+) 
cells  in  the spleen is  about 31%. At 100% CRL(+) cells,  the anti-SRBC response 
was not significantly  different  from background, as  expected in  the absence of  T 
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Of particular interest, cultures to which no CRL (+) cells were added produced 
small but significant PFC responses (1,754 _+ 564 per culture). These responses 
were entirely abrogated by treating the cells with anti-Thy-1 serum and comple- 
ment before culture (32 PFC per culture). In contrast, anti-Thy-1 treatment had 
no effect on the PFC response of CRL(-) cells to DNP-Ficoll (see above).  Since 
contamination of the CRL(-) population by CRL(+) cells could account for no 
more than about 75 PFC per culture, which would not be significantly different 
from background, the results suggest that at least a  small subpopulation of 
CRL(-) B cells make T-dependent antibody responses. 
Response of CRL( +  ) and CRL(-) Cells to a Polyclonal B-Cell Mitogen.  The 
CRL(+)  and CRL(-) B-cell  fractions were tested for their capacity to make 
proliferative responses to bacterial LPS, an established polyclonal mitogen for B 
cells. Both cell types made vigorous responses, although the CRL(-) cells were 
significantly more responsive in these assays than CRL(+) cells (Table IV). 
Neither population responded to Con A. 
Discussion 
The findings reported here indicate that B cells in A/J mice specific for the 
ABA epitepe reside largely or exclusively in a subpopulation which requires T- 
cell cooperation, whereas B  cells directed against the DNP determinant are 
found in T-independent as well as T-dependent compartments. The two subpop- 
ulations can be distinguished by the cell surface receptor for C3, which is present 
on T-dependent B cells but absent on those which respond to T-independent 
antigens. The evidence supporting this conclusion derives from the C3 depletion 
experiments in vivo reported here and elsewhere (7), in which antibody re- 
spohses to ABA and DNP epitopes on T-dependent carriers were largely abro- 
gated by CoV, whereas the PFC response to DNP on a T-independent carrier 
was unaffected. More definitively, the demonstration that the response to DNP- 
ficoll could be enriched in the CRL(-) population of B cells,  prepared by EAC 
rosette fractionation, established not only that C3  did not participate in the 
response, but that precursor cells specific for this T-independent antigen did not, 
in fact, express C3 receptors. The C3 receptor, therefore, can be considered a 
marker for B cells which respond to T-dependent antigens. 
Bitter-Suerman and colleagues have postulated that T-independent antigens 
activate B lymphecytes on the basis of their capacity to trigger the alternate 
complement pathway (22). While many T-independent antigens such as LPS 
possess this capacity as well as polyclonal mitogenicity, Ficoll neither activates 
the  alternate pathway nor has  appreciable mitogenic activity (23), findings 
which have been confirmed by us (unpublished observations). The two types of 
antigens are further distinguished by the cells on which they act; LPS activates 
CRL(+) as well as CRL(-) B cells, whereas Ficoll stimulates only the latter 
population. CRL(+) anti-ABA memory cells generated by priming with ABA- 
KLH could not be triggered by ABA-Ficoll.  Experiments to determine if such 
memory cells can be triggered by ABA-LPS conjugates are in progress. 
The anti-ABA PFC  response in A/J mice has several curious features. In 
addition to the absence of a response to ABA-Ficoll, the response to ABA-KLH 
requires hapten as well as carrier priming, is essentially a pure IgG response, G.  K.  LEWIS,  R.  RANKEN,  D.  E.  NITECKI,  AND  J.  W.  GOODMAN  393 
TABLE IV 
Responses of CRL( +) and CRL(-) B Cells to Polyclonal 
Mitogens 
Cell type 
Mitogen 
LPS*  Con A* 
Splenic B  cells  4.17 _+_ 0.295  ---_1 
CRL(+) B cells  9.71  _+ 2.95  -<1 
CRL(-) B cells  26.20 _+ 4.33  _-<1 
* 5  x  105 cells cultured with 0.5-5 ~g LPS or 1-2 ~g Con A. 
5 Stimulation  index  =  (cpm  14C-thymidine  incorporated  in  cultures 
containing  mitogen)/(cpm  14C-thymidine  incorporated  in  cultures 
without mitogen). 
and exhibits a critical temporal relationship between priming and boosting. In 
order to consistently obtain PFC responses, a 4 wk period must elapse between 
priming and boosting, while boosting is generally ineffective ai~r the 9th wk. 
Some of these features are explicable in terms of a very small precursor pool for 
the ABA epitope. Priming expands the pool of  responsive cells, an interpretation 
which is consistent with the appearance of ABA-specific RFC after priming, and 
the expanded memory cell population produces IgG antibody after secondary 
stimulation. The regulatory mechanism that limits the functional lifetime of 
ABA-specific memory cells to approximately 1-2 mo is unknown. 
It  is noteworthy that  an  anti-ABA IgM response to ABA-Ficoll has been 
obtained in CBA/N mice using a tripeptide spacer between the ABA group and 
the carrier (24). Spacers of this type have been shown to influence the class of 
antibody  formed against  the  phosphorylcholine epitope  (25). Therefore,  the 
possibility remains that the IgM antibody in that study was directed against at 
least a portion of the spacer peptide as well as the ABA group. It would be of 
considerable interest to know if these anti-ABA PFC reside in the CRL(-) B-cell 
compartment. 
An additional noteworthy finding in the present investigation is that the 7S as 
well as the 19S PFC response to DNP-Ficoll was unaffected by C3 depletion, in 
contrast to the 7S PFC response to DNP-BGG. This observation, together with 
the almost exclusive residence of the in vitro anti-DNP-Ficoll response in the 
CRL(-) B-cell fraction, indicates the two IgG responses have different signall- 
ing or triggering requirements, one in which C3 is obligatory and the other in 
which it  is  apparently uninvolved. We  interpret the findings to  mean that 
clearly distinctive B-cell subpopulations respond to T-dependent and to true 
(nonpolyclonal mitogen) T-independent antigens. 
The response of CRL  (-) B cells to SRBC further complicates the picture. Since 
this  response  was  sensitive  to  anti-Thy-1  serum  and  contamination of the 
CRL(-) cultures by CRL(+) B cells could not have accounted for its magnitude, 
it seems clear that at least a  subpopulation of CRL(-) B  cells is capable of 
cooperating with T cells in response to T-dependent antigens. This conclusion is 
consistent with observations of Pepys (7), who found significant residual anti- 
body levels in animals depleted of C3 by CoV before immunization with SRBC, 
and of Parish (26) and Parish and Chilcott (27), who reported that RBC were 394  SUBPOPULATION  OF  B  CELLS 
capable of stimulating both CRL(+) and CRL(-) B cells in the presence of a T- 
cell signal. Of interest, in the adoptive secondary response to horse RBC, at least 
50% of the responsive B cells were in the CRL(-) population (26), whereas in the 
present investigation the CRL(+) population housed approximately six times as 
many precursors for SRBC as did the CRL(-) population. This difference may be 
time related, since Parish and Chilcott allowed at least 3 wk between priming 
and boosting while we allowed only 4 days. It is conceivable that the rate of 
generation of B-cell memory differs in the two populations. 
Models for B-cell activation have generally postulated a single class of B cells 
capable of responding to both T-dependent and T-independent forms of antigen 
(1). Thymus dependency requires a minimum of two signals, one provided by the 
antigen  and  a  second derived from the T  cell.  According to  this model, T- 
independent antigens functionally bypass T  cells by generating both signals. 
While this may be true, for example, in the triggering of CRL(+) B  cells by 
polyclonal mitogens such as LPS and polymerized flagellin (28), it is a  less 
attractive  hypothesis for  the  activation of CRL(-)  B  cells by hapten-Ficoll 
conjugates. The advent of distinctive B-cell subpopulations with the properties 
described herein raises the possibility that they have entirely different signaling 
requirements.  It  is  probably  premature  to  speculate  at  this  point  about 
the number of signals generated by true T-independent antigens. However, a 
plausible  working model based  on the  present findings and  those reported 
elsewhere and discussed above is depicted in Fig. 6. CRL(+) B cells comprise 
about 80% of the splenic B-cell population, make only T-dependent responses, 
and are activated by dual signals provided by antigen and T cells, the latter via 
conversion of C3 to C3b. This signal is likely provided by a nonantigen-specific 
T-cell factor which can be replaced by any complement-activating  molecule such 
as LPS. The CRL(-) B cells which make T-dependent responses are envisaged 
here as a  subpopulation distinct from those which make true T-independent 
responses, although that has yet to be proven. A marker which can distinguish 
between the functional subsets of CRL(-) cells is required; a potential candidate 
may be  the Ia  antigen found on B  cells  (29). We propose that  CRL(-),  T- 
dependent B cells are activated by an antigen-specific T-cell factor via the Ia 
marker. This hypothesis is amenable to experimental test since anti-Ia antisera 
are available. The T-independent subpopulation of CRL(-) B cells have signal- 
ling requirements which can be satisfied by antigens of appropriate structure. 
LPS can activate CRL(+) and CRL(-) cells, but it is assumed that the effective 
signal it delivers to each type differs. Finally, it is unclear at present whether 
these B-cell  subsets  represent  different terminal  differentiation products or 
merely different stages in a  single differentiation pathway, but this question, 
too, is amenable to experimental elucidation. 
The almost total abrogation of T-dependent antibody responses by C3 deple- 
tion in vivo suggests that this complement component is an essential require- 
ment for such responses. This raises interesting questions about the relationship 
between soluble helper factors released by activated T cells (30), C3, and B-cell 
activation.  It has already been postulated that T  cells may function in  the 
cooperative process by releasing proteases which generate active split products 
of C3,  and that  the  interaction of such products with B  cells renders them G.  K.  LEWIS,  R.  RANKEN,  D.  E.  NITECKI,  AND  J.  W.  GOODMAN  395 
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FIG.  6.  A  schematic  model  of putative  B-cell  subpopulations  in  the  mouse  and  their 
signalling requirements. 
susceptible to activation by T-dependent antigens (31). In that context, it would 
be of extreme interest to determine if  purified helper factors from T cells degrade 
C3 and if split products of C3 can substitute for T cells in T-dependent antibody 
responses. Hartmann and Bokisch have recently shown that a relatively small 
fraction of murine B lymphocytes  can be transformed by human C3b (32). More 
definitive information might be  obtained in  a  homologous system in  which 
specific antibody responses are assayed. 
Summary 
Strain A/J mice made secondary indirect plaque-forming cell (PFC) responses 
to azobenzenearsonate (ABA) conjugates of giant keyhole limpet hemocyanin 
(KLH),  a  thymic-dependent antigen,  but  not  to  conjugates of Ficoll,  a  T- 
independent antigen. ABA-Ficoll was also unable to elicit a response in animals 
primed with ABA-KLH, which have an expanded anti-ABA memory cell pool. 
On the other hand, ABA-Ficoll rendered mice unresponsive to ABA-KLH when 
administered before priming or boosting with the T-dependent immunogen. 
Hence, the T-independent antigen was able to tolerize but unable to trigger B- 
memory cells responsive to the T-dependent antigen. A/J mice immunized with 
dinitrophenyl conjugates of Ficoll or bovine IgG (BGG) made vigorous IgM and 
IgG PFC responses. PFC responses to ABA-KLH and 2,4-dinitrophenyl (DNP)- 
BGG were abrogated by depleting mice of C3 with cobra venom factor, whereas 
the IgM and IgG PFC responses to DNP-Ficoll were unaffected. B lymphocytes 
were fractionated on the basis of receptors for C3 and the subpopulations were 
assayed for in vitro PFC  responses to  DNP-Ficoll.  Very little response was 
obtained  from complement receptor lymphocyte [CRL(+)]  B  cells,  whereas 
CRL(-) cells were more responsive than unfractionated B cells.  Both popula- 
tions responded to a polyclonal B-cell mitogen (lipepolysaccharide). On the other 396  SUBPOPULATION  OF  B  CELLS 
hand, the in vitro PFC response to a T-dependent antigen (sheep erythrocytes) 
correlated with the presence  of CRL(+) B  cells in the cultures.  However, a 
minor component of this response, sensitive to anti-Thy-1 serum, was made by 
CRL(-) B  cells,  indicating the existence of subpopulations of T-dependent B 
cells with different signalling requirements. 
The results suggest that most B  cells responsive to T-dependent antigens 
possess receptors for C3 and that C3 plays an obligatory role in the response of 
these cells. A distinct subpopulation of B cells which lack C3 receptors respond 
to T-independent antigens. The precursors of PFC for the ABA epitope reside 
largely or exclusively in the C RL  (+) compartment in A/J mice, whereas precur- 
sors for the DNP determinant are found in both compartments. 
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